搜索优化
English
全部
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按相关度排序
按时间排序
19 天
FDA批准ImmunityBio膀胱癌药物扩大使用范围
加利福尼亚州卡尔弗城 - 市值24.6亿美元的免疫疗法公司ImmunityBio, Inc. (NASDAQ: IBRX )获得美国食品和药物管理局(FDA)授权,批准其扩大使用计划(EAP),为美国膀胱癌治疗提供新的卡介苗(BCG)来源。这一进展是为了应对过去一年影响患者治疗的TICE® BCG短缺问题。根据 InvestingPro ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Prince of Luxembourg dies
Carney to replace Trudeau
'Self-deportation' app
Jets intercept 2 aircraft
Atlanta teacher's body found
Taps new acting ICE director
Southern California quake
North Sea collision
Billboard Woman of the Year
Says most programs dead
Volcano of Fire erupts
When is total lunar eclipse?
Says X hit by cyberattack
Trump on TikTok deal
Former Steelers OL dies
Electricity surcharge on US
Menendez brothers case
On conversion therapy case
To stream 'The Apprentice'
NK fires ballistic missiles?
Arrives in Saudi Arabia
Court-martial convenes
Tornado touches down in FL
NJ Transit, engineers deal
Chinese tariffs take effect
Harvard freezes hiring
On bid to block climate suits
Top columnist resigns
Judge declares mistrial
Winter weather warnings
Climate change impact study
No longer in danger
NASA's strategic shakeup
Long Island brush fires cause
Playwright Fugard dies
Measles case in Maryland
Iran to consider talks w/ US
反馈